SCHEMBL8569592

SCHEMBL8569592

COc1cccc(C(=O)c2cccnc2N)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 6/20 0.53
CDK5R1 Q15078 6/20 0.53
PARP1 P09874 1/20 0.53
CES2 O00748 1/20 0.51
CES1 P23141 1/20 0.51
STS P08842 2/20 0.51
HTT P42858 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TP53 P04637 1/20 0.49
GSK3A P49840 1/20 0.49
GSK3B P49841 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.49
CYP2C8 P10632 1/20 0.49
PKM P14618 2/20 0.48
CCNA2 P20248 1/20 0.48
CDK2 P24941 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
MEN1 O00255 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2679986 0.84 KMT2A (0.55) CDK5CDK5R1HTTNPC1RAB9A
SCHEMBL5365864 0.83 CES2 (0.51) PARP1CES2CES1STSHTT
SCHEMBL28747256 0.83 CES2 (0.51) CDK5CDK5R1PARP1CES2CES1
SCHEMBL8694860 0.82 KMT2A (0.56) CDK5CDK5R1PARP1CES2CES1
SCHEMBL7370589 0.82 ALDH1A1 (0.55) PARP1CES2CES1STSHTT
SCHEMBL3244377 0.81 CES2 (0.49) CDK5CDK5R1PARP1CES2CES1
SCHEMBL7369720 0.81 ELANE (0.49) CDK5CDK5R1PARP1CES2CES1
SCHEMBL29476675 0.81 MKNK1 (0.56) CDK5CDK5R1PARP1CES2CES1
SCHEMBL7921178 0.81 KMT2A (0.44) KDM4EMEN1KMT2ANAPRTALDH1A1
SCHEMBL4267213 0.80 GAA (0.59) PARP1CES2CES1STSHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626373-B1 Quinazolinone derivatives SUMITOMO PHARMA (JP) 1998-12-23 EP disclosed
US-5556860-A ANTIISCHEMIC AGENTS, BRAIN DISORDERS AND BLOOD METAL CONCENTRATIONS AND KIDNEY DISEASE SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1996-09-17 US disclosed
EP-0626373-A1 Quinazolinone derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-30 EP disclosed